Ipca Laboratories (IPCALAB) Share Price rises 2.21% today as stock trades near Rs 1,962.45
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Ipca Laboratories Share Price is in focus today as IPCALAB trades at Rs 1,962.45, up 2.21%, with market capitalisation of Rs 49,967.05 crore. The move places Ipca Laboratories Share Price among the notable share price rise names in Healthcare even as the latest Univest figures do not establish a company-specific catalyst. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Ipca Laboratories Share Price Today, the important point is the verified intraday price action, the company’s valuation profile and how it compares with the Pharmaceuticals & Drugs universe. Investors following Ipca Laboratories Stock News can use today’s move to review the stock’s fundamentals, sector positioning and peer context without turning the gain into a directional call. The latest Univest figures also show a market setup that is informative even without a fresh company event.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,962.45 |
| Previous Close | Rs 1,920.05 |
| Today's Move | Rs 42.4 (+2.21%) |
| Open | Rs 1,912.05 |
| High | Rs 1,967.5 |
| Low | Rs 1,912.05 |
| Market Capitalisation | Rs 49,967.05 crore |
| Market Cap Category | Large Cap |
Ipca Laboratories Ltd. (IPCALAB) rose to Rs 1,962.45 from the previous close of Rs 1,920.05, a move of Rs 42.4 or 2.21%. The stock opened at Rs 1,912.05, reached a high of Rs 1,967.5, recorded a low of Rs 1,912.05.
Ipca Laboratories Share Price rose steadily in intraday trade, moving from Rs 1,912.05 at the open to Rs 1,967.50 at the day high before last trading at Rs 1,962.45. The stock was up Rs 42.40 from the previous close of Rs 1,920.05, which translates into a 2.21% gain. The day’s low was Rs 1,912.05, matching the open and showing that the stock stayed above that level through the move. For readers checking Ipca Laboratories Share Price Today, this is a clear price rise backed by verified trading levels rather than a narrative assumption. Ipca Laboratories Share Price therefore enters today’s Stock Market Today conversation as a gainers’ name on price action alone. The latest Univest figures show a clean intraday move, and the next logical step is to examine whether the fundamentals and sector backdrop add context to the move.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,967.05 crore |
| P/E Ratio | 37.19x |
| P/B Ratio | 5.74x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.31% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 37.19x, P/B 5.74x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 49,967.05 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.19x, P/B at 5.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.19x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 5.74x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 49,967.05 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Ipca Laboratories Ltd. (IPCALAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.19x, which is above the benchmark median of 32.59x, a difference of +14.11%. On its own, the P/E gap is a valuation reference point, not a trading call.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.7%, a difference of +35.73%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.61%, a difference of +42.62%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.19x compared with the displayed peer median of 36.5x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 15.88% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 49,967.05 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price is rising today with a verified 2.21% gain and a high of Rs 1,967.50.
- The stock’s P/E of 37.19 and P/B of 5.74 keep Ipca Laboratories Fundamental Analysis relevant to current price action.
- ROE of 15.88% and ROCE of 19.41% place Ipca Laboratories Share Price above the industry median on returns.
- Healthcare sector benchmarking shows Ipca Laboratories Share Price in a valuation band above the industry median.
- Peer comparison with Zydus Lifesciences, Cipla, Sun Pharmaceutical and Divi’s Laboratories adds context to Ipca Laboratories Stock News.
About Ipca Laboratories
Ipca Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Ipca Laboratories Share Price reflects a business that is part of India’s broader pharmaceutical manufacturing and marketing universe, where company financials are often assessed through earnings, book value and return ratios. The available profile places the company in a large listed-capitalisation bracket with a market capitalisation of Rs 49,967.05 crore. For Ipca Laboratories Share Price Today, the business context matters because pharma stocks are often read through product mix, earnings quality and valuation discipline. The company’s EPS of 51.63 and book value of 334.38 help frame that discussion, while the dividend yield of 0.31% indicates a modest payout profile. In stock analysis terms, Ipca Laboratories Stock News today is best viewed through this mix of operating returns, valuation and industry positioning rather than through a single intraday print.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Ipca Laboratories Share Price rising today?
Ans. Ipca Laboratories Share Price is rising today because the stock is showing a verified 2.21% intraday gain. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Ipca Laboratories Share Price Today?
Ans. Ipca Laboratories Share Price Today is Rs 1,962.45. The stock is up Rs 42.40 from the previous close of Rs 1,920.05, which gives the move a clear intraday price action context.
What is the market capitalisation of Ipca Laboratories?
Ans. Ipca Laboratories has a market capitalisation of Rs 49,967.05 crore. That places Ipca Laboratories Share Price in a large listed-company bracket, which is useful context for valuation and peer comparison.
Is Ipca Laboratories Share Price expensive compared with peers?
Ans. Ipca Laboratories Share Price has a P/E of 37.19 and P/B of 5.74. Both sit above the industry median, so the stock trades at a richer valuation than the benchmark centre.
How do ROE and ROCE look for Ipca Laboratories?
Ans. Ipca Laboratories reports ROE of 15.88% and ROCE of 19.41. Both are above the industry median, which adds useful context to Ipca Laboratories Fundamental Analysis alongside today’s price rise.
What do EPS and book value say about Ipca Laboratories Share Price?
Ans. EPS is 51.63 and book value is 334.38. EPS reflects earnings attributable to each share, while book value per share shows accounting net worth behind each share in Ipca Laboratories Share Price analysis.
How does Ipca Laboratories compare with Healthcare peers?
Ans. Ipca Laboratories Share Price has a lower market cap than Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals, but its ROE and ROCE compare well with several peers in the Pharmaceuticals & Drugs industry.
What should investors watch next in Ipca Laboratories Share News?
Ans. Investors can watch whether Ipca Laboratories Share Price holds near current levels, how its valuation is read against the industry median, and whether any fresh company news changes the present price-rise backdrop.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Ipca Laboratories Share Price on Univest to follow live share price, key fundamentals, 52-week levels and market insights in one place. The Univest stock page helps readers compare Ipca Laboratories Share Price Today with company ratios, sector context and peer data as new market updates appear. For those scanning Ipca Laboratories Latest News, Univest keeps the discussion anchored in verified numbers and a clean stock analysis format.
